GLPG Galapagos NV ADRs

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:GLPG.

$60.00  +0.09 (0.15%)
As of 07/26/2021 15:59:56 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Belgium
Country of incorporation:  Belgium
IPO date:  07/07/2008
Outstanding shares:  65,522,521
Average volume:  439,793
Market cap:   $3,938,558,737
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    36315X101
ISIN:        US36315X1019
Sedol:      B292NQ7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.45
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%